154.00 -2.25 (-1.44%)

34.06% Fall from 52W High

11,566 NSE+BSE Volume

NSEJul 30, 2021 03:31 PM



Bafna Pharmaceuticals Ltd.    
27 Jul 2021
154.00
-1.44%
BAFNA PHARMACEUTICALS LTD. - 532989 - Board Meeting Intimation for Intimation Of Board Meeting Of The ...
BSE India
BAFNA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2021 ,inter alia, to consider and approve Notice is hereby given that a meeting of the Board of Directors of the Company will be held on Thursday, 05th August 2021 online through video conferencing, to inter alia consider and adopt un-audited financial results for the first quarter ending 30th June 2021 and any other business with the permission of the Chair. Further in accordance with the Code of Conduct for prevention of Insider Trading pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 the trading window for dealing in securities of the Company shall remain closed until 48 hours after the financial results approved at the meeting are made public.
default
Bafna Pharmaceuticals Ltd.    
26 Jul 2021
154.00
-1.44%
BAFNA PHARMACEUTICALS LTD. - 532989 - Discrepancies In Standalone Financial Results
BSE India
We acknowledge the receipt of your email dated 17th July 2021 and our reply is as follow: Discrepancy: In PDF of Cash Flow Statement - Closing Balance of Cash & Cash Equivalent Not Tallying.(Confirm Net Increase/ [Decrease] In Cash or cash Equivalents Figure is Positive & Negative).Kindly File Rectified Figures of Cash Flow Statement. Company's Reply Revised Cash Flow Statement is attached herewith.
Bafna Pharmaceuticals Ltd.    
26 Jul 2021
154.00
-1.44%
BAFNA PHARMACEUTICALS LTD. - 532989 - Book Closure For The Purpose Of Annual General Meeting
BSE India
We would like to inform you that, further to our announcement dated 25th June 2021 the Company's register of members will be closed from 07th August 2021 to 14th August 2021 (both days inclusive) for the purpose of annual general meeting. Security Code Type of security and paid up value Book closure Record date Purpose From to 532989 (BSE) BAFNAPH(NSE) Equity shares Rs.10/- paid up 07th August 2021 (Saturday) 14th August 2021 (Saturday) Both day inclusive N.A Annual General Meeting scheduled to be held on 14th August 2021
Bafna Pharmaceuticals Ltd.    
26 Jul 2021
154.00
-1.44%
Bafna Pharmaceuticals Ltd - 532989 - Book Closure For The Purpose Of Annual General Meeting
BSE India
We would like to inform you that, further to our announcement dated 25th June 2021 the Company's register of members will be closed from 07th August 2021 to 14th August 2021 (both days inclusive) for the purpose of annual general meeting. Security Code Type of security and paid up value Book closure Record date Purpose From to 532989 (BSE) BAFNAPH(NSE) Equity shares Rs.10/- paid up 07th August 2021 (Saturday) 14th August 2021 (Saturday) Both day inclusive N.A Annual General Meeting scheduled to be held on 14th August 2021
Bafna Pharmaceuticals Ltd.    
22 Jul 2021
154.00
-1.44%
BAFNA PHARMACEUTICALS LTD. - 532989 - Reg. 34 (1) Annual Report
BSE India
Pursuant to Regulation 34 (1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report of the Company for the financial year 2020-21 along with Notice of Annual General Meeting, which is being sent in electronic mode to the Shareholders of the Company. The said Annual Report 2020-21 has also been updated on the Company's website at www.bafnapharma.com.
default
Bafna Pharmaceuticals Ltd.    
20 Jul 2021
154.00
-1.44%
BAFNA PHARMACEUTICALS LTD. - 532989 - Shareholding for the Period Ended June 30, 2021
BSE India
Bafna Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here
Bafna Pharmaceuticals Ltd.    
14 Jul 2021
154.00
-1.44%
Bafna Pharmaceuticals Ltd - 532989 - Statement Of Investor Complaints For The Quarter Ended June 2021
BSE India
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Jitendra Kumar PalDesignation :- Company Secretary and Compliance Officer
Bafna Pharmaceuticals Ltd.    
09 Jul 2021
154.00
-1.44%
default
Bafna Pharmaceuticals Ltd.    
30 Jun 2021, 04:47PM
154.00
-1.44%
Bafna Pharmaceuticals Ltd.    
25 Jun 2021
154.00
-1.44%
BUY
SELL
HOLD
66.67%
26.67%
6.67%